Mesoblast Limited
MEOBF
$1.90
$0.2515.15%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.67M | -8.67M | -20.08M | -20.08M | -27.10M |
| Total Depreciation and Amortization | 2.14M | 2.14M | 2.15M | 2.15M | 2.16M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.78M | 2.78M | 11.67M | 11.67M | 11.62M |
| Change in Net Operating Assets | -2.99M | -2.99M | -8.91M | -8.91M | -1.33M |
| Cash from Operations | -6.74M | -6.74M | -15.17M | -15.17M | -14.65M |
| Capital Expenditure | -205.50K | -205.50K | -211.00K | -211.00K | -287.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.50K | -2.50K | -92.50K | -92.50K | 33.50K |
| Cash from Investing | -208.00K | -208.00K | -303.50K | -303.50K | -253.50K |
| Total Debt Issued | 25.00M | 25.00M | 35.68M | 35.68M | -- |
| Total Debt Repaid | -28.41M | -28.41M | -35.24M | -35.24M | -3.09M |
| Issuance of Common Stock | 2.37M | 2.37M | 2.78M | 2.78M | 82.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.06M | -6.06M | -3.78M | -3.78M | -3.63M |
| Cash from Financing | -7.10M | -7.10M | -564.00K | -564.00K | 75.80M |
| Foreign Exchange rate Adjustments | 521.00K | 521.00K | 251.50K | 251.50K | 864.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.53M | -13.53M | -15.79M | -15.79M | 61.76M |